X4 Pharmaceuticals, Inc. (XFOR)
4.04
-0.19
(-4.49%)
USD |
NASDAQ |
Aug 28, 16:00
4.12
+0.08
(+1.98%)
After-Hours: 20:00
X4 Pharmaceuticals Cash from Investing (Quarterly) : -1.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.00M |
| March 31, 2026 | 19.25M |
| December 31, 2025 | 16.85M |
| September 30, 2025 | -28.67M |
| June 30, 2025 | 23.11M |
| March 31, 2025 | -3.138M |
| December 31, 2024 | -8.621M |
| September 30, 2024 | -15.93M |
| June 30, 2024 | 96.86M |
| March 31, 2024 | -5.322M |
| December 31, 2023 | -4.833M |
| September 30, 2023 | -5.157M |
| June 30, 2023 | -4.884M |
| March 31, 2023 | -0.009M |
| December 31, 2022 | -0.034M |
| September 30, 2022 | -0.009M |
| June 30, 2022 | -0.038M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -0.013M |
| September 30, 2021 | -0.02M |
| June 30, 2021 | -0.086M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.496M |
| December 31, 2020 | -0.302M |
| September 30, 2020 | -0.496M |
| June 30, 2020 | -0.009M |
| March 31, 2020 | -0.555M |
| December 31, 2019 | 0.021M |
| September 30, 2019 | 0.815M |
| June 30, 2019 | -0.01M |
| March 31, 2019 | 26.41M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.017M |
| September 30, 2017 | 8.267M |
| June 30, 2017 | -6.74M |
| March 31, 2017 | -1.586M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.138M |
| June 30, 2016 | 0.056M |
| March 31, 2016 | -0.056M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -93.37M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | -0.013M |
| Anixa Biosciences, Inc. | 0.422M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.79M |
| Cash from Financing (Quarterly) | 0.075M |
| Free Cash Flow | -88.74M |
| Free Cash Flow Per Share (Quarterly) | -0.2041 |
| Free Cash Flow to Equity (Quarterly) | -25.76M |
| Free Cash Flow to Firm (Quarterly) | -23.62M |
| Free Cash Flow Yield | -21.62% |